UCSF COVID-19 Vaccine Information Hub

Updated March 19, 2021

UCSF is taking a phased, equity-driven approach to vaccine distribution for our workforce, students and patients. This page provides the latest information about our distribution plans.

UCSF is offering COVID-19 vaccines by appointment at the William J. Rutter Center located at the Mission Bay campus and at City College of San Francisco. Vaccines are no longer being offered at the UCSF Parnassus Heights campus.

Vaccine supplies remain limited and shipments to UCSF are unpredictable. This may affect vaccine appointment availability and require a limited number of appointments to be rescheduled. Those eligible for their first or second dose, or who need to reschedule, should check MyChart for newly available appointments on Tuesday evenings or Wednesday mornings.

Please remember that vaccines are just one tool to help protect against COVID-19. Until the pandemic has ended, everyone­ – including those who have been vaccinated – should continue to:

  • Follow public health orders
  • Wear masks
  • Physically distance
  • Wash hands regularly
  • Avoid unnecessary travel and gatherings
  • Complete daily health screening (for employees and learners)
  • Wear appropriate eye protection (for all employees in clinical areas)

Latest Updates

  • March 21, 2021: UCSF has closed its Parnassus Heights vaccine clinic. The Rutter Center and City College of San Francisco vaccine sites remain open by appointment.
  • March 18, 2021: UCSF has rescheduled some Pfizer second dose appointments due to limited supply. Notifications were sent to those affected. 
  • March 16, 2021: Vaccine eligibility expanded to include those with co-morbidities, the unhoused, and others. 
  • March 9, 2021: Update to Vaccine Facts and Resources to include approval of Johnson & Johnson vaccine.
  • Feb. 24, 2021: Chief Clinical Officer Josh Adler announces the tier of vaccine-eligible populations and how UCSF staff can sign up.

Distribution Phases

  • Health care workers and first responders
  • UCSF faculty and staff, under state eligibility criteria for employees of colleges and universities
  • Adults age 50 and over, or age 16-64 with co-morbidities
  • Workers in education, formal or informal childcare, libraries, foster care or children’s residential care facilities
  • Workers in food & agriculture, transportation, utilities or disaster services
  • Documented direct caregivers
  • Individuals who are unhoused or live in a high-risk congregate setting
  • Second doses for those who received their first dose at a UCSF vaccination site


Vaccine Guidance


Vaccine Facts and Resources

Vaccines Approved for Use in the U.S.

The table below summarizes what’s known and not yet known about each of the COVID-19 vaccines that have been granted Emergency Use Authorization from the U.S Food and Drug Administration.

  Pfizer Moderna Johnson & Johnson
Date Vaccine Authorized by FDA Dec. 11, 2020 Dec. 18, 2020 Feb. 27, 2021
Vaccine Technology mRNA vaccine mRNA vaccine Modified adenovirus
Populations Authorized for Vaccination People age 16 and older People age 18 and older People age 18 and older
Number of Doses Required 2 2 1
Days Between First and Second Dose 21 28 n/a
Peak Efficacy 95% effective at preventing symptomatic disease 94.1% effective at preventing symptomatic disease 85% effective at preventing severe disease*
When Peak Efficacy is Reached 7 days after Dose #2 7 days after Dose #2 28 days after vaccination
How Long Immunity Lasts TBD TBD TBD

*The clinical trials for the Johnson & Johnson vaccine assessed different COVID-19 symptoms and were conducted at different times during the pandemic. All three vaccines were found to be effective in reducing or preventing severe disease, hospitalization and death from COVID-19.


Frequently Asked Questions

If you are a UCSF patient, find more FAQs on the Patient Hub.

More vaccine questions? Email [email protected]